Candesartan vs Ipilimumab

## Candesartan vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Candesartan** and **Ipilimumab**.

## Mechanism of Action

**Candesartan**: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Candesartan — 9 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Molecular Formula**: Candesartan — C33H34N6O6; Ipilimumab — N/A.

**Molecular Weight**: Candesartan — 610.6640 g/mol; Ipilimumab — N/A.

**Type**: Candesartan — Small molecule; Ipilimumab — Antibody.